Related Experiment Video
Updated: Aug 6, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
CDC20 Regulates the Progression of Clear Cell Renal Cell Carcinoma via the Wnt/β-Catenin Signaling Pathway
YuHu Hao1, Leizuo Zhao2, Yanning Sun1
1Department of Urology, Shandong Provincial Hospital, Shandong University, Jinan 250021, China, sdu.edu.cn.
Objective:
To detect the expression level of cell division cycle 20 homolog (CDC20) in clear cell renal cell carcinoma (ccRCC) and to study the biological function of CDC20 in ccRCC.
Methods:
CDC20 expression levels and clinical significance of ccRCC were determined using the Cancer Genome Atlas (TCGA) database. We detected the expression level of CDC20 in ccRCC with the help of immunohistochemistry (IHC). The effect of CDC20 on the proliferation of renal cancer cells was investigated using EDU and CCK-8 proliferation assays. We used wound healing assays and Transwell assays to determine the effects of CDC20 on renal cancer cell migration and invasion and Wnt signaling pathway agonists in recovery experiments. The mechanism of CDC20 in ccRCC was detected using western blotting. Finally, the effect of CDC20 on renal cancer cells was verified in vivo in a nude mouse xenograft model.
Results:
Bioinformatics analysis found that CDC20 was upregulated in ccRCC, and its high expression was associated with poor prognosis in kidney renal cell carcinoma (KIRC) patients. In addition, we detected high expression of CDC20 in KIRC tissues, consistent with the results of bioinformatics analysis. Besides, knockdown of CDC20 can inhibit the biological functions of renal cancer cells. The recovery experiment proved that the biological function of the originally inhibited renal cancer cells was restored. In vivo, low expression of CDC20 can inhibit tumor growth.
Conclusions:
As CDC20 is highly expressed in KIRC tissues, it can be used as both a therapeutic target and a prognostic marker.
Insights
Cell division cycle 20 homolog (CDC20) is upregulated in clear cell renal cell carcinoma (ccRCC), correlating with poor prognosis. Targeting CDC20 may offer a new therapeutic strategy for ccRCC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Clear cell renal cell carcinoma (ccRCC) is a significant cause of cancer-related mortality.
- The role of cell division cycle 20 homolog (CDC20) in ccRCC pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the expression levels of CDC20 in ccRCC.
- To explore the biological functions and prognostic significance of CDC20 in ccRCC.
Main Methods:
- Utilized The Cancer Genome Atlas (TCGA) database for bioinformatics analysis.
- Performed immunohistochemistry (IHC), EDU, CCK-8, wound healing, and Transwell assays.
- Verified findings in vivo using a nude mouse xenograft model and western blotting for mechanistic studies.
Main Results:
- CDC20 was found to be upregulated in ccRCC, with high expression linked to poorer prognosis in kidney renal cell carcinoma (KIRC) patients.
- Knockdown of CDC20 inhibited renal cancer cell proliferation, migration, and invasion.
- In vivo studies demonstrated that reduced CDC20 expression suppressed tumor growth.
Conclusions:
- High CDC20 expression in KIRC tissues suggests its potential as a therapeutic target.
- CDC20 serves as a valuable prognostic marker for KIRC patients.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...